Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

Documenti analoghi

• Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. No cytogenetic data were reported.
  di: Kingdom, J., et al.
  Pubblicazione: (1997)
• Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. During pregnancy, heparin should be stopped during labour and then restarted soon after delivery.
  di: Piette, J. C., et al.
  Pubblicazione: (1997)
• Treatment of pregnant women with recurrent miscarriage associated with phospholipid antibodies. General prognosis is favourable in untreated women.
  di: Christiansen, O. B.
  Pubblicazione: (1997)
• Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage
  di: Elmahashi, Mohamed O, et al.
  Pubblicazione: (2014)
• Combination of aspirin and heparin in unexplained recurrent miscarriages – “Empirical or evidence based”
  di: Jain, Prakriti, et al.
  Pubblicazione: (2011)